Topic: semaglutide

Latest

MHRA approves new use of semaglutide for cardiovascular prevention

MHRA approves new use of semaglutide for cardiovascular prevention

NHSE medical director 'alarmed' by reports of inappropriate weight loss drug use

NHSE medical director 'alarmed' by reports of inappropriate weight loss drug use

14th June 2024

NICE recommends tirzepatide for NHS primary care

NICE recommends tirzepatide for NHS primary care

7th June 2024

Semaglutide helps heart failure symptoms in patients with obesity and type 2 diabetes

Semaglutide helps heart failure symptoms in patients with obesity and type 2 diabetes

23rd April 2024

GLP 1 Receptor Agonists Not Linked To Suicidal Thoughts, PRAC Concludes

GLP-1 receptor agonists not linked to suicidal thoughts, PRAC concludes

17th April 2024

Diabetes drug shows potential in treating Parkinson’s disease

Diabetes drug shows potential in treating Parkinson’s disease

15th April 2024

Notification issued for multiple GLP1-RA shortages

Notification issued for multiple GLP1-RA shortages

19th March 2024

Mounjaro weight loss service hoped to ease supply issues

Mounjaro weight loss service hoped to ease supply issues

16th February 2024

Patients Hospitalised From 'potentially Fake' Weight Loss Pens

Patients hospitalised from 'potentially fake' weight-loss pens

30th October 2023

MHRA finds fake Ozempic pens in UK supply chain

MHRA finds fake Ozempic pens in UK supply chain

20th October 2023

Tirzepatide approval sparks hope though supply warnings remain

Tirzepatide approval sparks hope though supply warnings remain

11th September 2023

There are no known supply issues with Wegovy, a weekly semaglutide weight-loss injection that launched in the UK this week, the government has said.

‘No known’ Wegovy supply issues, says DHSC

5th September 2023

‘Controlled and limited launch’ of Wegovy from today

‘Controlled and limited launch’ of Wegovy from today

4th September 2023

Semaglutide cuts risk of cardiovascular events by 20%, claims manufacturer

Semaglutide cuts risk of cardiovascular events by 20%, claims manufacturer

9th August 2023

Regulators Issue Statement On GLP 1 RA Prescribing

Regulators issue statement on GLP-1 RA prescribing

20th July 2023

Pharmacists and GPs call for diabetes drug supply protection

Pharmacists and GPs call for diabetes drug supply protection

11th July 2023

GLP-1 receptor agonists shortage expected until 2025

GLP-1 receptor agonists shortage expected until 2025

4th July 2023